Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix

By Felberbaum RE  

Human Reproduction, Vol. 13, Iss. 6, 1998-06 ,pp. : 1660-1668

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin

By Albano C.  

Human Reproduction, Vol. 15, Iss. 3, 2000-03 ,pp. : 526-531

Oxford University Press

Access to resources Recommend Favorite

Luteinizing Hormone-Releasing Hormone Analogue-Induced Cataract in a Patient with Prostate Cancer

By  

Medical Principles and Practice, Vol. 16, Iss. 2, 2007-02 ,pp. : 161-163

Karger

Access to resources Recommend Favorite

Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation

By Tiboni Gian Mario   Palumbo Paola   Leonzio Emiliana   Gabriele Elisabetta   Verna Ilde   Giampietro Franca  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 885-889

Informa Healthcare

Access to resources Recommend Favorite

Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers

By Duijkers IJM  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2392-2398

Oxford University Press

Access to resources Recommend Favorite